With a commitment to process optimization, training, and audits to enhance their operations, CROs can ensure the integrity of medications throughout the trial process. The Fast Company Executive Board ...
A collaborative study by the Tufts Center for the Study of Drug Development and CRIO identifies protocol interpretation and ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Bari Kowal, Senior Vice President, Development Operations & Portfolio Management at Regeneron Clinical trial innovation is a hot topic, but it’s not a new one. The first fully virtual randomized trial ...
The adoption of AI in clinical trials holds the potential to revolutionize how therapies are discovered, but the pace of that ...
Business leaders must understand what patient-centric care really requires. Too often, patients, researchers and investors ...
Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and expectations from regulators, payers, and patients continue to rise. Meanwhile, ...
Her career has taken her from treating patients to developing new medicines for biopharma, and now Nancy L. Lewis, MD, MBS, ...
TOKYO & MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results